SGMD logo.png
Sugarmade Signs Definitive Agreement to Acquire California Cannabis Licenses to Provide for the Opening of Three New Vertically Integrated Nug Avenue Locations
31 août 2021 08h30 HE | Sugarmade, Inc.
NEW YORK, Aug. 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Sugarmade, Inc. (OTCMKTS:SGMD) (“Sugarmade,” “SGMD,” or the “Company”), an emerging leader in the vertically integrated cannabis...
ExCellThera and Aste
ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
13 juil. 2021 08h05 HE | ExCellThera
MONTREAL, July 13, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune...
ssgc_logo.jpg
Sharing Services Global Corporation (SHRG) Receives Notice on South Korea License
21 mai 2021 17h15 HE | Sharing Services Global Corporation
PLANO, Texas, May 21, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Sharing Services Global Corporation (OTCQB: SHRG) (the “Company”), formerly Sharing Services, Inc., has received notice from KOSSA...
Form fit function.png
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
22 avr. 2021 16h30 HE | Conformis, Inc.
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific...
Form fit function.png
Conformis Announces License Agreement with Paragon 28
19 avr. 2021 16h30 HE | Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Cend_ID_Color.jpg
Cend Therapeutics and Qilu Pharmaceutical Announce Partnership
16 févr. 2021 08h00 HE | Cend Therapeutics Inc.
SAN DIEGO and JINAN, China, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Cend Therapeutics, Inc., a clinical-stage biotech company, and Qilu Pharmaceutical, a major Chinese pharmaceutical company, announced...
W2Email Logo.jpg
Way2Grow (W2G) Biopharma Company Enters Cannabis Productivity and Announces Plans to Seek Health Canada Approval for Magic Mushroom (Psilocybin and Psilocin) Dealer and Research Licencing
15 déc. 2020 08h17 HE | Way2Grow Nurseries
OSOYOOS, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately held biopharma company, is pleased to announce it is...
DEINOVE signe une li
DEINOVE signe une licence d'évaluation et de développement technologique avec DSM
19 nov. 2020 12h30 HE | Deinove
DEINOVE signe une licence d'évaluation et de développement technologique avec DSM DEINOVE (Euronext Growth Paris : ALDEI), société de biotechnologie française pionnière dans l’exploration et...
DEINOVE signs an Eva
DEINOVE signs an Evaluation and Technology Development License with DSM
19 nov. 2020 12h30 HE | Deinove
DEINOVE signs an Evaluation and Technology Development License with DSM DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that pioneers the application of biodiversity from the...
UpRyze.jpg
UpRyze Cannabis Ltd., an Indigenous-run micro-cultivator of craft cannabis, receives its Health Canada license
05 oct. 2020 13h35 HE | UpRyze Cannabis Ltd.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ACHESON, Alberta, Oct. 05, 2020 (GLOBE NEWSWIRE) -- UpRyze Cannabis Ltd. (the “Company” or “UpRyze”) is...